MedPath

Neuroimage Genome Study of Neuroplasticity Associated With Microgravity

Active, not recruiting
Conditions
MRI
Microgravity
Neuroplasticity
Repeatable Battery for the Assessment of Neuropsychological Status
Registration Number
NCT06350422
Lead Sponsor
Chinese PLA General Hospital
Brief Summary

This clinical trial investigates the neuroplasticity and cognitive status changes of the human brain in microgravity. To explore the relationship between cognitive status changes and brain functional activities, gray matter and white matter changes under microgravity exposure, screen and identify representative image markers, so as to provide decision-making information for the cognitive status changes of relevant personnel under microgravity environment.

Detailed Description

MRI has the advantage of non-invasive and non-radiation, and imaging the human brain after exposure to microgravity can reveal the neuroplastic changes in the astronaut's brain and discover the characteristics of functional activities behind it. The purpose of this study is to explore the image features and cognitive state related information related to the changes of human brain neuroplasticity under microgravity environment, and to identify the related image markers. At the same time, the pathophysiological mechanism is preliminarily discussed in this study. This study is helpful for us to explore the sensitivity of different brain structures and brain functions to space microgravity environment, so as to further understand the role and influence of space missions on brain health.

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
Male
Target Recruitment
26
Inclusion Criteria
  • Male aged 18-60 years
  • No mental or other neurological disorders, no history of drug or alcohol abuse
  • Generally in good condition, no clear major physical diseases, no hearing disorders
  • No metal foreign bodies in the body, no contraindications to MRI scanning
  • No claustrophobia
  • Agree to participate in the clinical study and sign the informed consent
Exclusion Criteria
  • There are electronic implants or metal foreign bodies, such as cardiac pacemakers
  • People with aneurysm surgery and intracranial aneurysm clip
  • People who have had heart surgery and used artificial heart valves
  • Having family planning
  • Uncontrolled epilepsy or mental illness, can't cooperate with MRI examination
  • Severe claustrophobia, can't cooperate with magnetic resonance examination
  • Other circumstances that the clinical trial personnel consider inappropriate to participate in the study

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Brain structure - Morphology60 days after the Head-Down tilt Bed Rest test

Based on 3D-T1WI, the changes of brain structure before and after the Head-Down tilt Bed Rest test were compared.

Local brain functional activity60 days after the Head-Down tilt Bed Rest test

Based on resting-state functional MRI images, the changes of local brain functional activity before and after the Head-Down tilt Bed Rest test were compared.

Brain functional connectivity60 days after the Head-Down tilt Bed Rest test

Based on resting-state functional MRI images, the changes of brain functional connectivity before and after the Head-Down tilt Bed Rest test were compared.

Brain fiber bundle and brain Diffusion index60 days after the Head-Down tilt Bed Rest test

Based on diffusion tensor imaging, the changes of brain fiber bundle and brain diffusion index before and after the Head-Down tilt Bed Rest test were compared.

Brain blood flow60 days after the Head-Down tilt Bed Rest test

Based on arterial spin labeling, the changes of brain blood flow before and after the Head-Down tilt Bed Rest test were compared.

Imaging indexes and clinical scale scores60 days after the Head-Down tilt Bed Rest test

Based on the changes of relevant imaging indexes and the changes of relevant clinical scale scores, explore the correlation between the changes of relevant imaging indexes and relevant clinical scales scores.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Chinese PLA General Hospital

🇨🇳

Beijing, China

© Copyright 2025. All Rights Reserved by MedPath